Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The DPP-4 inhibitors were well-tolerated in combination with insulin and did not cause weight gain
Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications
There are a variety of interventions to assess a patient's risk of suicide, depending on their individual situation
While weight loss generally benefits heart failure patients, dehydration from gastrointestinal side effects may require adjustment of diuretic therapy
